Business · 31/10/2007

FDA Releases Draft Guidance on Financial Disclosure for Advisory Committee Members

The Food and Drug Administration (FDA) has made public a draft guidance document outlining procedures for the public, advisory committee members, and FDA staff to disclose financial interests and obtain waivers to participate in advisory committee meetings, superseding a 2002 guidance on conflict of interest disclosure.